Impact of COVID-19 pandemic on cardiac, respiratory and mental health through collaboration with physician, psychologist, Nursing, Nutritional and Epidemiological specialist
Main Article Content
Keywords
pandemic, healthcare provider, mental status, cardiac and respiratory issue, COVID-19 long effects.
Abstract
The COVID-19 pandemic significantly changed the focus of healthcare Team. In susceptible patient populations, these modifications may have had an impact on respiratory, cardiac, and mental health. The long-term effects of COVID-19 are not as well understood, however they can include persistence, sequelae, and other medical issues that last weeks or months after the initial recovery. In particular, as health care providers struggle to combat COVID-19, we also need to determine how the pandemic has affected people's cardiac, respiratory, and mental health. In conclusion, extended COVID represents a multifaceted illness with prolonged and varied symptoms, necessitating individualized care and continuous assistance for individuals experiencing COVID-19 aftereffects. On the other hand, an effective interprofessional team is essential to a crisis response's effectiveness. Aim: The purpose of the current systematic review is to locate studies that examine and evaluate the consequences of COVID-19 pandemic on cardiac, respiratory and mental health through a collaboration with physician, psychologist, Nursing, Nutritional and Epidemiological specialist. Design: A systematic review was formed from 32 studies that were included. Conclusion The respiratory, cardiovascular, and neurological systems have been intimately associated with the COVID-19 pandemic since its inception. The COVID-19 sequelae are a developing issue in the post-epidemic era. In order to investigate and control the course of the anomalies in the respiratory, cardiac sequelae of COVID-19 and its effect on mental health, A clinical, Nursing, psychological, Nutritional, pandemic control features should be taken into consideration. Careful monitoring of the disease in survivors is necessary
References
Visco V, Vitale C, Rispoli A, Izzo C, Virtuoso N, Ferruzzi GJ, Santopietro M, Melfi A, Rusciano MR, Maglio A, et al. (2022) Post-COVID-19 Syndrome: Involvement and Interactions between Respiratory, Cardiovascular and Nervous Systems. Journal of Clinical Medicine. 11(3):524.
Rugulies R. (2002). Depression as a predictor for coronary heart disease: a review and meta-analysis. Am J Prev Med. 23:51–61.
Kapoor MC. Respiratory and cardiovascular effects of COVID-19 infection and their management. (2020). J Anaesthesiol Clin Pharmacol : S21-S28.
Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19).
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020; 323:1061–9.
Ahmad, M.S.; Shaik, R.A.; Ahmad, R.K.; Yusuf, M.; Khan, M.; Almutairi, A.B.; Alghuyaythat, W.K.Z.; Almutairi, S.B. (2021). “LONG COVID”: 25, 5561–5577.
Goldman J., Xyrichis A. (2020). Interprofessional working during the COVID-19 pandemic: sociological insights. J Interprof Care.;34(5):580–582.
Coelho-Ravagnani CF, Corgosinho FC, Sanches FFZ et al.(2021). Dietary recommendations during the COVID-19 pandemic. 79:382–93.
Campoe K. (2020). Interprofessional collaboration during COVID-19.29(September-October 2020;(5):297–298
Rugulies R. (2002). Depression as a predictor for coronary heart disease: a review and meta-analysis. Am J Prev Med. 23:51–61.
Bordoni B, Marelli F, Morabito B et al. (2018). Depression and anxiety in patients with chronic heart failure. Future Cardiol. 14:115–9
Gehi A, Haas D, Pipkin S, Whooley M. (2005). Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study. 165:2508–13.
Kluge HHP, Wickramasinghe K, Rippin HL et al. (2020). Prevention and control of non-communicable diseases in the COVID-19 response. Lancet. 395:1678–80.
Long, Q.; Li, J.; Hu, X.; Bai, Y.; Zheng, Y.; Gao, Z. (2021). Follow-Ups on Persistent Symptoms and Pulmonary Function Among Post-Acute COVID-19 Patients: A Systematic Review and Meta-Analysis. 8, 702635.
Huang, C.; Huang, L.; Wang, Y.; Li, X.; Ren, L.; Gu, X.; Kang, L.; Guo, L.; Liu, M.; Zhou, X.; et al. (2021). 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study., 397, 220–232
Tavazzi G, Pellegrini C, Maurelli M, Belliato M, Sciutti F, Bottazzi A, et al. (2020). Myocardial localization of coronavirus in COVID-19 cardiogenic shock. 22:911–5.
Xiong TY, Redwood S, Prendergast B, Chen M. (2020). Coronaviruses and the cardiovascular system: Acute and long-term implications. 41:1798–800.
Inciardi RM, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D, et al. (2020). Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19) JAMA Cardiol.
American College of Cardiology. (2020). HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19.
Bertagnin E, Greco A, Bottaro G et al. (2021). Remote monitoring for heart failure management during COVID-19 pandemic. 32:100724.
Radin, J.M.; Quer, G.; Ramos, E.; Baca-Motes, K.; Gadaleta, M.; Topol, E.J.; Steinhubl, S.R. (2021). Assessment of Prolonged Physiological and Behavioral Changes Associated With COVID-19 Infection., e2115959.
Puntmann, V.O.; Carerj, M.L.; Wieters, I.; Fahim, M.; Arendt, C.; Hoffmann, J.; Shchendrygina, A.; Escher, F.; Vasa-Nicotera, M.; Zeiher, A.M.; et al. (2020) Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered from Coronavirus Disease 2019 (COVID-19), 5, 1265–1273.
D’Errico, S.; Zanon, M.; Montanaro, M.; Radaelli, D.; Sessa, F.; Di Mizio, G.; Montana, A.; Corrao, S.; Salerno, M.; Pomara, C. (2020). More than pneumonia: Distinctive features of sars-cov-2 infection. From autopsy findings to clinical implications: A systematic review. Microorganisms, 8, 1642.
Shi, S.; Qin, M.; Cai, Y.; Liu, T.; Shen, B.; Yang, F.; Cao, S.; Liu, X.; Xiang, Y.; Zhao, Q.; et al. (2020). Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019., 41, 2070–2079
Piazza, G.; Campia, U.; Hurwitz, S.; Snyder, J.E.; Rizzo, S.M.; Pfeferman, M.B.; Morrison, R.B.; Leiva, O.; Fanikos, J.; Nauffal, V.; et al. (2020). Registry of arterial and venous thromboembolic complications in patients with Covid-19. 76, 2060–2072
Korkmaz, B.; Lesner, A.; Marchand-Adam, S.; Moss, C.; Jenne, D.E. (2020). Lung protection by cathepsin c inhibition: A new hope for Covid-19 and ards63, 13258–13265
Sakr, Y.; Giovini, M.; Leone, M.; Pizzilli, G.; Kortgen, A.; Bauer, M.; Tonetti, T.; Duclos, G.; Zieleskiewicz, L.; Buschbeck, S.; et al. (2020). Pulmonary embolism in patients with coronavirus disease-2019 (Covid-19) pneumonia: A narrative review., 10, 124.
Sidarta-Oliveira, D.; Jara, C.P.; Ferruzzi, A.J.; Skaf, M.S.; Velander, W.H.; Araujo, E.P.; Velloso, L.A. (2020). Sars-cov-2 receptor is co-expressed with elements of the kinin-kallikrein, renin-angiotensin and coagulation systems in alveolar cells. Sci., 10, 19522.
Grosse, C.; Grosse, A.; Salzer, H.J.F.; Dunser, M.W.; Motz, R.; Langer, R. (2020). Analysis of cardiopulmonary findings in Covid-19 fatalities: High incidence of pulmonary artery thrombi and acute suppurative bronchopneumonia., 49, 107263.
Lorkiewicz, P.; Waszkiewicz, N. (2021). Biomarkers of Post-COVID Depression. 10, 4142.
Serrano-Castro, P.J.; Estivill-Torrus, G.; Cabezudo-Garcia, P.; Reyes-Bueno, J.A.; Ciano Petersen, N.; Aguilar-Castillo, M.J.; Suarez-Perez, J.; Jimenez-Hernandez, M.D.; Moya-Molina, M.A.; Oliver-Martos, B.; et al. (2020). Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: A delayed pandemic? Neurologia, 35, 245–251.
Nersesjan, V.; Amiri, M.; Lebech, A.M.; Roed, C.; Mens, H.; Russell, L.; Fonsmark, L.; Berntsen, M.; Sigurdsson, S.T.; Carlsen, J.; et al. (2021). Central and peripheral nervous system complications of COVID-19: A prospective tertiary center cohort with 3-month follow-up., 268, 3086–3104
Wijeratne, T.; Crewther, S. (2020). Post-COVID 19 Neurological Syndrome (PCNS); a novel syndrome with challenges for the global neurology community., 419, 117179.
Renaud-Charest, O.; Lui, L.M.W.; Eskander, S.; Ceban, F.; Ho, R.; Di Vincenzo, J.D.; Rosenblat, J.D.; Lee, Y.;(2021). Subramaniapillai, M.; McIntyre, R.S. Onset and frequency of depression in post-COVID-19 syndrome: A systematic review. J. Psychiatr., 144, 129–137.
Bo, H.X.; Li, W.; Yang, Y.; Wang, Y.; Zhang, Q.; Cheung, T.; Wu, X.; Xiang, Y.T. (2021). Posttraumatic stress symptoms and attitude toward crisis mental health services among clinically stable patients with COVID-19 in China. 51, 1052–1053.
Raciti, L.; Calabro, R.S. (2021). Neurological complications of COVID-19: From pathophysiology to rehabilitation. An overview. 92, e2021317.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.